Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
- Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 1
- Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 2
- Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 3
- Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 4
- image label - venlafaxine hcl er cadila 5
Product Label Images
The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 53217-194 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 1

This text seems to be a documentation of drug interactions and their effects on the PK (pharmacokinetics) of different analytes. The interacting drugs mentioned include Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The effects of these drugs on CYP2D6 EM's and PM's are highlighted. The analyte mentioned in the text is Venlafaxine. There are recommendations for the use of these drugs in patients - some require dose adjustments, while others need to be avoided or used with caution, especially in patients with hypertension, elderly, or hepatic dysfunction. The text mentions PK Fold Change and 90% C recommendation, but it's not clear what they refer to.*
Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 2

This document appears to be a chart of different drugs and their interactions. The first column lists a variety of drugs, while the second column includes some type of code or identifier. The remaining columns list various parameters for each drug including their PKFold change and recommended dosage adjustments. The end of the document includes a section on changes relative to a reference value, but it is not clear what this is referring to.*
Venlafaxine hydrochloride extended-release capsules, USP - venlafaxine hcl er cadila 3

This text appears to be a chart or table providing information on recommended dose adjustments for the drug venlafaxine based on various factors such as age, kidney and liver function, and genetic factors. The table recommends reducing the dose of venlafaxine by various percentages depending on these factors, and suggests individualized dosing may be necessary in some cases. There are also measurements of Cmax and AuC, as well as information on fold change and 90% CI.*
image label - venlafaxine hcl er cadila 5

This is a description of Venlafaxine HCL ER, USP, a medication with a National Drug Code (NDC) of 53217-0194-60 and 60 capsules per package. Each capsule contains 150mg of active ingredients which are Venlafaxine Hydrochloride, USP and Venlafaxine Hel ER, USP (equivalent to Venlafaxine 150mg). The capsules are white and dark orange oblong-shaped with ZA-37 150mg imprinted on one side, and are the generic version of Effexor XR. It is manufactured by Cadila Healthcare Limited in India and distributed by Pharmaceuticals. This description provides dosage instructions in Spanish and a chart log for the patient's use.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.